1. Home
  2. ASRT vs MNOV Comparison

ASRT vs MNOV Comparison

Compare ASRT & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • MNOV
  • Stock Information
  • Founded
  • ASRT 1995
  • MNOV 2000
  • Country
  • ASRT United States
  • MNOV United States
  • Employees
  • ASRT N/A
  • MNOV N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • MNOV Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASRT Health Care
  • MNOV Health Care
  • Exchange
  • ASRT Nasdaq
  • MNOV Nasdaq
  • Market Cap
  • ASRT 85.1M
  • MNOV 91.7M
  • IPO Year
  • ASRT 1997
  • MNOV 2005
  • Fundamental
  • Price
  • ASRT $0.80
  • MNOV $1.90
  • Analyst Decision
  • ASRT Strong Buy
  • MNOV Strong Buy
  • Analyst Count
  • ASRT 4
  • MNOV 1
  • Target Price
  • ASRT $3.19
  • MNOV $9.00
  • AVG Volume (30 Days)
  • ASRT 357.9K
  • MNOV 21.3K
  • Earning Date
  • ASRT 03-10-2025
  • MNOV 02-18-2025
  • Dividend Yield
  • ASRT N/A
  • MNOV N/A
  • EPS Growth
  • ASRT N/A
  • MNOV N/A
  • EPS
  • ASRT N/A
  • MNOV N/A
  • Revenue
  • ASRT $125,763,000.00
  • MNOV N/A
  • Revenue This Year
  • ASRT N/A
  • MNOV N/A
  • Revenue Next Year
  • ASRT $1.84
  • MNOV N/A
  • P/E Ratio
  • ASRT N/A
  • MNOV N/A
  • Revenue Growth
  • ASRT N/A
  • MNOV N/A
  • 52 Week Low
  • ASRT $0.73
  • MNOV $1.12
  • 52 Week High
  • ASRT $1.80
  • MNOV $2.55
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 43.92
  • MNOV 45.15
  • Support Level
  • ASRT $0.78
  • MNOV $1.87
  • Resistance Level
  • ASRT $0.83
  • MNOV $2.06
  • Average True Range (ATR)
  • ASRT 0.03
  • MNOV 0.08
  • MACD
  • ASRT 0.00
  • MNOV 0.00
  • Stochastic Oscillator
  • ASRT 39.86
  • MNOV 47.48

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

Share on Social Networks: